nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.559	1	CbGaD
Zuclopenthixol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0416	0.346	CbGbCtD
Zuclopenthixol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0416	0.346	CbGbCtD
Zuclopenthixol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0371	0.308	CbGbCtD
Zuclopenthixol—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.0128	0.445	CbGeAlD
Zuclopenthixol—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00465	0.161	CbGeAlD
Zuclopenthixol—DRD2—respiratory system—chronic obstructive pulmonary disease	0.00119	0.0412	CbGeAlD
Zuclopenthixol—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000937	0.0325	CbGeAlD
Zuclopenthixol—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000825	0.0286	CbGeAlD
Zuclopenthixol—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000811	0.0281	CbGeAlD
Zuclopenthixol—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000783	0.0272	CbGeAlD
Zuclopenthixol—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000758	0.0263	CbGeAlD
Zuclopenthixol—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000755	0.0262	CbGeAlD
Zuclopenthixol—HRH1—trachea—chronic obstructive pulmonary disease	0.000693	0.024	CbGeAlD
Zuclopenthixol—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000689	0.0239	CbGeAlD
Zuclopenthixol—ADRA2A—trachea—chronic obstructive pulmonary disease	0.00068	0.0236	CbGeAlD
Zuclopenthixol—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00063	0.0219	CbGeAlD
Zuclopenthixol—DRD2—lung—chronic obstructive pulmonary disease	0.00063	0.0219	CbGeAlD
Zuclopenthixol—HTR2A—trachea—chronic obstructive pulmonary disease	0.000579	0.0201	CbGeAlD
Zuclopenthixol—Flupentixol—HTR2A—chronic obstructive pulmonary disease	0.000502	0.0658	CrCbGaD
Zuclopenthixol—HRH1—lung—chronic obstructive pulmonary disease	0.000498	0.0173	CbGeAlD
Zuclopenthixol—ADRA2A—lung—chronic obstructive pulmonary disease	0.000489	0.017	CbGeAlD
Zuclopenthixol—HTR2A—lung—chronic obstructive pulmonary disease	0.000416	0.0144	CbGeAlD
Zuclopenthixol—Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.000401	0.0525	CrCbGaD
Zuclopenthixol—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.0017	CcSEcCtD
Zuclopenthixol—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000393	0.0017	CcSEcCtD
Zuclopenthixol—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.00168	CcSEcCtD
Zuclopenthixol—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00168	CcSEcCtD
Zuclopenthixol—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00168	CcSEcCtD
Zuclopenthixol—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Zuclopenthixol—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Zuclopenthixol—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Zuclopenthixol—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Zuclopenthixol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Zuclopenthixol—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Zuclopenthixol—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.00167	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00166	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00166	CcSEcCtD
Zuclopenthixol—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00166	CcSEcCtD
Zuclopenthixol—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00166	CcSEcCtD
Zuclopenthixol—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00164	CcSEcCtD
Zuclopenthixol—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00164	CcSEcCtD
Zuclopenthixol—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00164	CcSEcCtD
Zuclopenthixol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00164	CcSEcCtD
Zuclopenthixol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00164	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000378	0.00163	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00163	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00163	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000371	0.00161	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000371	0.00161	CcSEcCtD
Zuclopenthixol—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.0016	CcSEcCtD
Zuclopenthixol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.00158	CcSEcCtD
Zuclopenthixol—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000365	0.0478	CrCbGaD
Zuclopenthixol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.00158	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00157	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00157	CcSEcCtD
Zuclopenthixol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00157	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00157	CcSEcCtD
Zuclopenthixol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000362	0.00157	CcSEcCtD
Zuclopenthixol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000362	0.00157	CcSEcCtD
Zuclopenthixol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00156	CcSEcCtD
Zuclopenthixol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00156	CcSEcCtD
Zuclopenthixol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00156	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000359	0.00155	CcSEcCtD
Zuclopenthixol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00155	CcSEcCtD
Zuclopenthixol—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00154	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00154	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00154	CcSEcCtD
Zuclopenthixol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00153	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00152	CcSEcCtD
Zuclopenthixol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.0015	CcSEcCtD
Zuclopenthixol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000347	0.0015	CcSEcCtD
Zuclopenthixol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000345	0.00149	CcSEcCtD
Zuclopenthixol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00149	CcSEcCtD
Zuclopenthixol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.00149	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00149	CcSEcCtD
Zuclopenthixol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.00148	CcSEcCtD
Zuclopenthixol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00147	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.00147	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00147	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000338	0.00146	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000338	0.00146	CcSEcCtD
Zuclopenthixol—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000338	0.0443	CrCbGaD
Zuclopenthixol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00145	CcSEcCtD
Zuclopenthixol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00145	CcSEcCtD
Zuclopenthixol—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000334	0.00145	CcSEcCtD
Zuclopenthixol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00144	CcSEcCtD
Zuclopenthixol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000332	0.00144	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000331	0.00143	CcSEcCtD
Zuclopenthixol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000331	0.00143	CcSEcCtD
Zuclopenthixol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000331	0.00143	CcSEcCtD
Zuclopenthixol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00143	CcSEcCtD
Zuclopenthixol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00143	CcSEcCtD
Zuclopenthixol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00142	CcSEcCtD
Zuclopenthixol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00142	CcSEcCtD
Zuclopenthixol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00141	CcSEcCtD
Zuclopenthixol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00141	CcSEcCtD
Zuclopenthixol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00141	CcSEcCtD
Zuclopenthixol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000326	0.00141	CcSEcCtD
Zuclopenthixol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000323	0.0014	CcSEcCtD
Zuclopenthixol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.0014	CcSEcCtD
Zuclopenthixol—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00139	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00139	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00139	CcSEcCtD
Zuclopenthixol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00032	0.00138	CcSEcCtD
Zuclopenthixol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00138	CcSEcCtD
Zuclopenthixol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00138	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000319	0.00138	CcSEcCtD
Zuclopenthixol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00137	CcSEcCtD
Zuclopenthixol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00137	CcSEcCtD
Zuclopenthixol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00137	CcSEcCtD
Zuclopenthixol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00137	CcSEcCtD
Zuclopenthixol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00137	CcSEcCtD
Zuclopenthixol—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00137	CcSEcCtD
Zuclopenthixol—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00137	CcSEcCtD
Zuclopenthixol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00136	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00136	CcSEcCtD
Zuclopenthixol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000314	0.00136	CcSEcCtD
Zuclopenthixol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000313	0.00135	CcSEcCtD
Zuclopenthixol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.00135	CcSEcCtD
Zuclopenthixol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00135	CcSEcCtD
Zuclopenthixol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00134	CcSEcCtD
Zuclopenthixol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00133	CcSEcCtD
Zuclopenthixol—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000308	0.00133	CcSEcCtD
Zuclopenthixol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00133	CcSEcCtD
Zuclopenthixol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000307	0.00133	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00132	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00132	CcSEcCtD
Zuclopenthixol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000306	0.00132	CcSEcCtD
Zuclopenthixol—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00132	CcSEcCtD
Zuclopenthixol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000304	0.00132	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.00131	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000304	0.00131	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00131	CcSEcCtD
Zuclopenthixol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00131	CcSEcCtD
Zuclopenthixol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.0013	CcSEcCtD
Zuclopenthixol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.0013	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00129	CcSEcCtD
Zuclopenthixol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00127	CcSEcCtD
Zuclopenthixol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00127	CcSEcCtD
Zuclopenthixol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00127	CcSEcCtD
Zuclopenthixol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00127	CcSEcCtD
Zuclopenthixol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00127	CcSEcCtD
Zuclopenthixol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00125	CcSEcCtD
Zuclopenthixol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00125	CcSEcCtD
Zuclopenthixol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00029	0.00125	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00125	CcSEcCtD
Zuclopenthixol—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.0378	CrCbGaD
Zuclopenthixol—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.0378	CrCbGaD
Zuclopenthixol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000288	0.00125	CcSEcCtD
Zuclopenthixol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00124	CcSEcCtD
Zuclopenthixol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00124	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.00124	CcSEcCtD
Zuclopenthixol—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000281	0.0368	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—chronic obstructive pulmonary disease	0.000278	0.0365	CrCbGaD
Zuclopenthixol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.0012	CcSEcCtD
Zuclopenthixol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.0012	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00118	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00118	CcSEcCtD
Zuclopenthixol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000273	0.00118	CcSEcCtD
Zuclopenthixol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.00118	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00116	CcSEcCtD
Zuclopenthixol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00115	CcSEcCtD
Zuclopenthixol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00115	CcSEcCtD
Zuclopenthixol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00114	CcSEcCtD
Zuclopenthixol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00114	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00113	CcSEcCtD
Zuclopenthixol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00113	CcSEcCtD
Zuclopenthixol—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.00026	0.034	CrCbGaD
Zuclopenthixol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00112	CcSEcCtD
Zuclopenthixol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00111	CcSEcCtD
Zuclopenthixol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000254	0.0011	CcSEcCtD
Zuclopenthixol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.0011	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.00109	CcSEcCtD
Zuclopenthixol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00109	CcSEcCtD
Zuclopenthixol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00108	CcSEcCtD
Zuclopenthixol—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.0326	CrCbGaD
Zuclopenthixol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00108	CcSEcCtD
Zuclopenthixol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00107	CcSEcCtD
Zuclopenthixol—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000247	0.0324	CrCbGaD
Zuclopenthixol—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000246	0.00107	CcSEcCtD
Zuclopenthixol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00106	CcSEcCtD
Zuclopenthixol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00106	CcSEcCtD
Zuclopenthixol—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000243	0.0319	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000243	0.0319	CrCbGaD
Zuclopenthixol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00104	CcSEcCtD
Zuclopenthixol—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00104	CcSEcCtD
Zuclopenthixol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00104	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00102	CcSEcCtD
Zuclopenthixol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00102	CcSEcCtD
Zuclopenthixol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00102	CcSEcCtD
Zuclopenthixol—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Zuclopenthixol—Rash—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Zuclopenthixol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Zuclopenthixol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Zuclopenthixol—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Zuclopenthixol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000233	0.00101	CcSEcCtD
Zuclopenthixol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.00101	CcSEcCtD
Zuclopenthixol—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00101	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.001	CcSEcCtD
Zuclopenthixol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.001	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000232	0.001	CcSEcCtD
Zuclopenthixol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000231	0.001	CcSEcCtD
Zuclopenthixol—Rash—Montelukast—chronic obstructive pulmonary disease	0.000229	0.000992	CcSEcCtD
Zuclopenthixol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000229	0.000991	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000989	CcSEcCtD
Zuclopenthixol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000228	0.000985	CcSEcCtD
Zuclopenthixol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000964	CcSEcCtD
Zuclopenthixol—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000222	0.000961	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000957	CcSEcCtD
Zuclopenthixol—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000956	CcSEcCtD
Zuclopenthixol—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000956	CcSEcCtD
Zuclopenthixol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000955	CcSEcCtD
Zuclopenthixol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.000954	CcSEcCtD
Zuclopenthixol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000221	0.000954	CcSEcCtD
Zuclopenthixol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.00095	CcSEcCtD
Zuclopenthixol—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000217	0.0285	CrCbGaD
Zuclopenthixol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000937	CcSEcCtD
Zuclopenthixol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000216	0.000934	CcSEcCtD
Zuclopenthixol—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0281	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—chronic obstructive pulmonary disease	0.000214	0.028	CrCbGaD
Zuclopenthixol—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.000923	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00092	CcSEcCtD
Zuclopenthixol—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.00021	0.0276	CrCbGaD
Zuclopenthixol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.000901	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000896	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000874	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00087	CcSEcCtD
Zuclopenthixol—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.0261	CrCbGaD
Zuclopenthixol—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000856	CcSEcCtD
Zuclopenthixol—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.0258	CrCbGaD
Zuclopenthixol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000849	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000841	CcSEcCtD
Zuclopenthixol—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000831	CcSEcCtD
Zuclopenthixol—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000192	0.0251	CrCbGaD
Zuclopenthixol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000807	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000803	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000795	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000787	CcSEcCtD
Zuclopenthixol—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000181	0.0237	CrCbGaD
Zuclopenthixol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.000781	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000779	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000774	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000774	CcSEcCtD
Zuclopenthixol—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.0226	CrCbGaD
Zuclopenthixol—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000744	CcSEcCtD
Zuclopenthixol—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.000169	0.0222	CrCbGaD
Zuclopenthixol—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00073	CcSEcCtD
Zuclopenthixol—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.000168	0.022	CrCbGaD
Zuclopenthixol—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000167	0.0219	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000167	0.0218	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—chronic obstructive pulmonary disease	0.000167	0.0218	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000166	0.0218	CrCbGaD
Zuclopenthixol—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.0218	CrCbGaD
Zuclopenthixol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000718	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000717	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000712	CcSEcCtD
Zuclopenthixol—Quetiapine—HTR2A—chronic obstructive pulmonary disease	0.000163	0.0214	CrCbGaD
Zuclopenthixol—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000698	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000696	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000694	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000681	CcSEcCtD
Zuclopenthixol—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000156	0.0205	CrCbGaD
Zuclopenthixol—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000671	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000669	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000659	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000657	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000655	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000651	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000641	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000632	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000622	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00062	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000617	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000614	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000611	CcSEcCtD
Zuclopenthixol—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.00014	0.0184	CrCbGaD
Zuclopenthixol—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000602	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000576	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000575	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000572	CcSEcCtD
Zuclopenthixol—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	0.000132	0.0173	CrCbGaD
Zuclopenthixol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000567	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000556	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000549	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000548	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000548	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000545	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000545	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00054	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000521	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000517	CcSEcCtD
Zuclopenthixol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000517	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.0005	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000116	0.0005	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000466	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000453	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000447	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000432	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000418	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000402	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000398	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000398	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000396	CcSEcCtD
Zuclopenthixol—Chlorpromazine—ALB—chronic obstructive pulmonary disease	9.03e-05	0.0118	CrCbGaD
Zuclopenthixol—Nausea—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000375	CcSEcCtD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.51e-05	0.00067	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.48e-05	0.000664	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.48e-05	0.000663	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.47e-05	0.000661	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.45e-05	0.000658	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.45e-05	0.000657	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.44e-05	0.000655	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.43e-05	0.000654	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.41e-05	0.00065	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.4e-05	0.000649	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.39e-05	0.000647	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.38e-05	0.000645	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.33e-05	0.000635	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.33e-05	0.000635	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.32e-05	0.000633	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.3e-05	0.00063	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.26e-05	0.000621	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.2e-05	0.000611	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.19e-05	0.000608	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.15e-05	0.000602	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.14e-05	0.000598	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.13e-05	0.000597	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.13e-05	0.000597	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.11e-05	0.000594	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.07e-05	0.000586	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.07e-05	0.000585	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.07e-05	0.000585	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.06e-05	0.000583	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.05e-05	0.000581	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.03e-05	0.000578	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.03e-05	0.000577	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3e-05	0.000572	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.9e-05	0.000552	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.87e-05	0.000546	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.85e-05	0.000544	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.85e-05	0.000544	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.85e-05	0.000543	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.85e-05	0.000543	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.84e-05	0.000542	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.82e-05	0.000537	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.8e-05	0.000535	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.8e-05	0.000533	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.79e-05	0.000532	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.79e-05	0.000532	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.77e-05	0.000528	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.75e-05	0.000524	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.73e-05	0.00052	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.73e-05	0.00052	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.68e-05	0.000512	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.68e-05	0.000511	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.68e-05	0.000511	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.68e-05	0.00051	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.67e-05	0.000509	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.67e-05	0.000508	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.67e-05	0.000508	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.64e-05	0.000504	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.63e-05	0.000502	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.63e-05	0.000501	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.63e-05	0.000501	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.62e-05	0.000499	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.59e-05	0.000494	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.59e-05	0.000493	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.58e-05	0.000491	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	2.57e-05	0.00049	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.55e-05	0.000486	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.55e-05	0.000486	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.54e-05	0.000484	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.54e-05	0.000484	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	2.51e-05	0.000479	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.49e-05	0.000475	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.49e-05	0.000475	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.48e-05	0.000473	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000469	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.46e-05	0.000468	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.45e-05	0.000467	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.44e-05	0.000465	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.44e-05	0.000465	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.4e-05	0.000458	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.37e-05	0.000452	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.35e-05	0.000448	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.32e-05	0.000442	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	2.29e-05	0.000437	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.27e-05	0.000432	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.26e-05	0.000432	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.23e-05	0.000426	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.22e-05	0.000424	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.18e-05	0.000416	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.15e-05	0.00041	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.14e-05	0.000408	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.000402	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.06e-05	0.000392	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.04e-05	0.000389	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.04e-05	0.000389	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.03e-05	0.000386	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.02e-05	0.000386	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.99e-05	0.00038	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.96e-05	0.000374	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.96e-05	0.000373	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.94e-05	0.000371	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.92e-05	0.000366	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.91e-05	0.000365	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.86e-05	0.000354	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.85e-05	0.000353	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.85e-05	0.000353	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.84e-05	0.000351	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.82e-05	0.000348	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.82e-05	0.000347	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.79e-05	0.000341	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.78e-05	0.00034	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.77e-05	0.000338	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.77e-05	0.000338	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.76e-05	0.000336	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.74e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.71e-05	0.000326	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.68e-05	0.000321	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.68e-05	0.00032	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.66e-05	0.000316	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.65e-05	0.000316	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.65e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.65e-05	0.000314	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000312	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.63e-05	0.00031	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.62e-05	0.000308	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.57e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.57e-05	0.000299	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.54e-05	0.000294	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000292	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.53e-05	0.000292	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.53e-05	0.000291	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000289	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.51e-05	0.000288	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.5e-05	0.000287	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.5e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.5e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.000285	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.49e-05	0.000284	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.48e-05	0.000283	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.47e-05	0.000281	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000273	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.000267	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.39e-05	0.000265	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.38e-05	0.000263	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.38e-05	0.000262	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.38e-05	0.000262	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.37e-05	0.000262	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.37e-05	0.000261	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.37e-05	0.000261	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.36e-05	0.00026	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.35e-05	0.000258	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.35e-05	0.000257	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.34e-05	0.000255	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.34e-05	0.000255	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-05	0.000255	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.34e-05	0.000255	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.31e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.29e-05	0.000246	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.29e-05	0.000246	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000242	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.000239	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.24e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.24e-05	0.000237	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.23e-05	0.000235	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000234	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.22e-05	0.000233	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.22e-05	0.000233	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.21e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.2e-05	0.000228	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.2e-05	0.000228	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.15e-05	0.000219	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000219	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.000216	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.11e-05	0.000212	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000209	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.000201	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000199	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.04e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.03e-05	0.000197	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-05	0.000193	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.01e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.99e-06	0.000191	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	9.97e-06	0.00019	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.9e-06	0.000189	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.85e-06	0.000188	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.76e-06	0.000186	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.6e-06	0.000183	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.58e-06	0.000183	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.48e-06	0.000181	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.4e-06	0.000179	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.31e-06	0.000178	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.29e-06	0.000177	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.25e-06	0.000176	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.16e-06	0.000175	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.15e-06	0.000174	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.14e-06	0.000174	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.97e-06	0.000171	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.89e-06	0.000169	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.73e-06	0.000167	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.34e-06	0.000159	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.26e-06	0.000158	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.16e-06	0.000156	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.13e-06	0.000155	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.11e-06	0.000155	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8e-06	0.000153	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.96e-06	0.000152	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.86e-06	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.8e-06	0.000149	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.73e-06	0.000147	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.71e-06	0.000147	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.57e-06	0.000144	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.47e-06	0.000142	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.4e-06	0.000141	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.35e-06	0.00014	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.34e-06	0.00014	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.2e-06	0.000137	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.14e-06	0.000136	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.03e-06	0.000134	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.79e-06	0.00013	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.72e-06	0.000128	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.71e-06	0.000128	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.69e-06	0.000128	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.6e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.59e-06	0.000126	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.5e-06	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.47e-06	0.000123	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.16e-06	0.000117	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.15e-06	0.000117	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.06e-06	0.000116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.05e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.04e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.01e-06	0.000115	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.94e-06	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.93e-06	0.000113	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.93e-06	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.82e-06	0.000111	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.51e-06	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.41e-06	0.000103	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.07e-06	9.67e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.99e-06	9.51e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.98e-06	9.49e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.88e-06	9.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.64e-06	8.85e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.57e-06	8.71e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.56e-06	8.69e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.54e-06	8.65e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.47e-06	8.53e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.15e-06	7.92e-05	CbGpPWpGaD
